Charles Rodenkirch is CEO of Sharper Sense, Inc. Sharper Sense, is commercializing his research into neuromodulation technology that enhances sensory acuity (clearer vision, hearing, and touch) while worn. This technology has great potential to enhance performance by optimizing mental state to reduce misperceptions and miscommunication. Website: www.SharperSense.com Dr. Rodenkirch is a systems neuroscientist, biomedical engineering, and computer scientist developing the next generation of neurotechnology. Specifically, bioelectronic methods of improving neural processes in order to treat neurological disorders and degeneration. Interested in technology at the intersection of electronics and neuroscience that positively impacts users’ lives. Further experience includes a fellowship with Columbia Technology Ventures and participation in selective business accelerators by ComcastNBC and Cornell University. His research uses the latest in brain-computer interfaces, biological tools, computational modeling, and statistical analysis to investigate how brain state (e.g. attention, arousal) affects sensory processing and perception. List of my publications here: https://scholar.google.com/citations?hl=en&user=g5EzSJEAAAAJ